How much does NEFECON (Budesonide Enteric Capsules) Cost& price without insurance in China?
NEFECON® is the commercial brand name of Budesonide Enteric Capsules, a targeted, delayed-release formulation of the synthetic corticosteroid budesonide developed by Everest Medicines. It is designed to deliver budesonide locally to the ileum, modulating the mucosal immune response to reduce pathogenic IgA production, thereby slowing kidney function decline in IgA nephropathy.
Main Indications
Treatment of adult patients with primary immunoglobulin A nephropathy (IgAN) at risk of disease progression, to reduce proteinuria and slow the loss of kidney function.
Common Side Effects
Common adverse reactions: Acne, hypertension, peripheral edema, facial edema, dyspepsia, headache, upper respiratory tract infection, muscle spasms, weight increase, and dermatitis.
These reactions are mostly mild to moderate in severity and reversible, reflecting the low systemic exposure of this targeted formulation.
Approval Status in China
NEFECON® (Budesonide Enteric Capsules, 4mg) was conditionally approved for marketing in China in November 2023. It is currently a prescription drug and included in China’s Category B medical insurance.
Buy NEFECON (Budesonide Enteric Capsules) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
